In the pre-treatment phase, a physician will go over a patient’s medical history and answer any medical questions or concerns in a virtual consultation. Next, patients will be scheduled for an in-person doctor’s consultation, skin prick test, and blood draw.
The interface is the relationship between allergic foods and an individual’s immune system. During this phase, we identify biosimilar proteins to retrain the immune system and safely build tolerance one protein at a time. Biosimilar proteins are proteins similar to those in a patient’s allergens.
Once a patient’s immune system is accustomed to biosimilar food proteins, they can safely begin to “challenge” their allergens in increasing amounts until complete Tolerance is achieved.